Logo image of GSS

Golden Star Resources Ltd (GSS) Stock Fundamental Analysis

NYSEARCA:GSS - NYSE Arca - Common Stock

3.9  +0.01 (+0.26%)

After market: 3.89 -0.01 (-0.26%)

Fundamental Rating

1

Taking everything into account, GSS scores 1 out of 10 in our fundamental rating. GSS was compared to 155 industry peers in the Metals & Mining industry. GSS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, GSS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year GSS was profitable.
GSS Yearly Net Income VS EBIT VS OCF VS FCFGSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA -2.56%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSS Yearly ROA, ROE, ROICGSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 -200 -400 -600 -800

1.3 Margins

Industry RankSector Rank
OM 13.45%
PM (TTM) -3.43%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GSS Yearly Profit, Operating, Gross MarginsGSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 -20 40

0

2. Health

2.1 Basic Checks

The number of shares outstanding for GSS has been increased compared to 1 year ago.
The debt/assets ratio for GSS is higher compared to a year ago.
GSS Yearly Shares OutstandingGSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M
GSS Yearly Total Debt VS Total AssetsGSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -1.83, we must say that GSS is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 17.49 is on the high side and indicates that GSS has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 17.49
Debt/FCF N/A
Altman-Z -1.83
ROIC/WACCN/A
WACCN/A
GSS Yearly LT Debt VS Equity VS FCFGSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 50M -50M 100M

2.3 Liquidity

GSS has a Current Ratio of 1.44. This is a normal value and indicates that GSS is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 0.95 indicates that GSS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.95
GSS Yearly Current Assets VS Current LiabilitesGSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 50M 100M

5

3. Growth

3.1 Past

GSS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.27%, which is quite impressive.
The Revenue has grown by 25.73% in the past year. This is a very strong growth!
Measured over the past years, GSS shows a small growth in Revenue. The Revenue has been growing by 1.32% on average per year.
EPS 1Y (TTM)92.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)25.73%
Revenue growth 3Y-4.77%
Revenue growth 5Y1.32%
Sales Q2Q%-13.3%

3.2 Future

GSS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.11% yearly.
The Revenue is expected to grow by 3.38% on average over the next years.
EPS Next Y-49.93%
EPS Next 2Y19.47%
EPS Next 3Y15.97%
EPS Next 5Y43.11%
Revenue Next Year-15.97%
Revenue Next 2Y-0.91%
Revenue Next 3Y-0.05%
Revenue Next 5Y3.38%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GSS Yearly Revenue VS EstimatesGSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
GSS Yearly EPS VS EstimatesGSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2

2

4. Valuation

4.1 Price/Earnings Ratio

GSS is valuated rather expensively with a Price/Earnings ratio of 21.67.
The average S&P500 Price/Earnings ratio is at 26.52. GSS is around the same levels.
A Price/Forward Earnings ratio of 7.79 indicates a rather cheap valuation of GSS.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.25, GSS is valued rather cheaply.
Industry RankSector Rank
PE 21.67
Fwd PE 7.79
GSS Price Earnings VS Forward Price EarningsGSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.94
GSS Per share dataGSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as GSS's earnings are expected to grow with 15.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.47%
EPS Next 3Y15.97%

0

5. Dividend

5.1 Amount

GSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Golden Star Resources Ltd

NYSEARCA:GSS (1/27/2022, 8:28:54 PM)

After market: 3.89 -0.01 (-0.26%)

3.9

+0.01 (+0.26%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)02-28 2022-02-28/amc
Inst Owners0.01%
Inst Owner Change0%
Ins Owners0.13%
Ins Owner Change0%
Market Cap451.33M
Analysts47.5
Price Target3.94 (1.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.67
Fwd PE 7.79
P/S 1.72
P/FCF N/A
P/OCF N/A
P/B 69.95
P/tB N/A
EV/EBITDA 7.94
EPS(TTM)0.18
EY4.62%
EPS(NY)0.5
Fwd EY12.85%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.27
BVpS0.06
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 13.45%
PM (TTM) -3.43%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 17.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.95
Altman-Z -1.83
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-49.93%
EPS Next 2Y19.47%
EPS Next 3Y15.97%
EPS Next 5Y43.11%
Revenue 1Y (TTM)25.73%
Revenue growth 3Y-4.77%
Revenue growth 5Y1.32%
Sales Q2Q%-13.3%
Revenue Next Year-15.97%
Revenue Next 2Y-0.91%
Revenue Next 3Y-0.05%
Revenue Next 5Y3.38%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A